Hendley & Co’s Pfizer PFE Stock Holding History

Hendley & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,166	Closed	-$227K	–	71
2020 Q4	$227K	Sell	6,166 -228	-4%	-$8.36K	0.09%	66
2020 Q3	$223K	Buy	+6,394	New	+$224K	0.09%	68

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hendley & Co's PFE Position: Q1 2021 in Review

Hendley & Co sold out of Pfizer (PFE) in Q1 2021, closing a stake of 6,166 shares — an estimated $227K sold.

Hendley & Co first reported a position in PFE in Q3 2020 and held it in 2 quarters. The position peaked at $227K in Q4 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

Hendley & Co reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
Hendley & Co sold 6,166 Pfizer shares in Q1 2021, an estimated $227K.
Hendley & Co first reported a position in Pfizer in Q3 2020 and held it in 2 quarters.
Hendley & Co's Pfizer position peaked at $227K in Q4 2020.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Hendley & Co's 13F filing for Q1 2021, filed 22 Apr 2021.